Optimising basal-bolus therapy in type 2 diabetes: a randomised, controlled trial comparing bolus insulin delivery using an insulin patch vs an insulin pen

被引：0

作者：

Ramtoola, S. ^{[1
]}

Aroda, V. R. ^{[2
]}

Bailey, T. S. ^{[3
]}

Brazg, R. L. ^{[4
]}

Dreon, D. M. ^{[5
]}

Frias, J. P.

Klonoff, D. C. ^{[6
]}

Kruger, D. F.

Levy, B. L. ^{[5
]}

Peyrot, M. ^{[7
]}

Rosenstock, J. ^{[8
]}

Serusclat, P. ^{[9
]}

Weinstock, R. S. ^{[10
]}

Zraicks, V.

Bergenstal, R. M. ^{[11
]}

机构：

[1] East Lancashire Hosp NHS Trust, Blackburn, Lancs, England

[2] Medstar Hlth Res Inst, Hyattsville, MD USA

[3] AMCR Inst Inc, Escondido, TN USA

[4] Rainier Clin Res Ctr, Renton, WA USA

[5] Calibra Med, Wayne, NJ USA

[6] Diabet Res Inst, San Mateo, NJ USA

[7] Loyola Univ Maryland, Baltimore, MD USA

[8] Dallas Diabet Res Ctr Med City, Dallas, TX USA

[9] Grp Hosp Mutualiste Portes Sud, Venissieux, France

[10] SUNY Upstate Med Univ, Syracuse, NY USA

[11] Int Diabet Ctr, Minneapolis, MN USA

来源：

DIABETOLOGIA | 2018年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

809

引用

页码：S397 / S397

页数：1

共 50 条

[41] Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
Billings, Liana K.
Doshi, Ankur
Gouet, Didier
Oviedo, Alejandra
Rodbard, Helena W.
Tentolouris, Nikolaos
Gron, Randi
Halladin, Natalie
Jodar, Esteban
DIABETES CARE, 2018, 41 (05) : 1009 - 1016
[42] Comparison of twice-daily injection of biphasic insulin Lispro and basal-bolus therapy in insulin naive patients with type 2 diabetes
Yamada, Satoru
Masuda, Haruka
Kitaoka, Akira
Shiono, Kaoru
Atsuda, Koichiro
Irie, Junichiro
Shimada, Akira
DIABETES, 2007, 56 : A537 - A538
[43] Faster-acting insulin aspart vs insulin aspart as part of basal-bolus therapy improves postprandial glycaemic control in uncontrolled type 2 diabetes: the onset® 2 trial
Bowering, K.
Case, C.
Harvey, J.
Reeves, M.
Sampson, M.
Strzinek, R.
Bretler, D. -M.
Bang, R. B.
Bode, B. W.
DIABETOLOGIA, 2016, 59 : S399 - S400
[44] Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients
Giugliano, D.
Cleall, S.
Pontiroli, A. E.
Koivisto, V.
DIABETOLOGIA, 2011, 54 : S421 - S422
[45] Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
Heller, Simon
Buse, John
Fisher, Miles
Garg, Satish
Marre, Michel
Merker, Ludwig
Renard, Eric
Russell-Jones, David
Philotheou, Areti
Francisco, Ann Marie Ocampo
Pei, Huiling
Bode, Bruce
LANCET, 2012, 379 (9825): : 1489 - 1497
[46] A RANDOMIZED TRIAL COMPARING BOLUS-ONLY INSULIN PATCH VERSUS PEN USING SIMPLE DOSE-TITRATION ALGORITHM IN TYPE 2 DIABETES PATIENTS NOT ACHIEVING GLYCEMIC TARGETS ON BASAL INSULIN
Johnson, M.
Dreon, D.
Zraick, V.
Levy, B.
Naik, R.
Bergenstal, R.
DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A121 - A121
[47] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
Urakami, Tatsuhiko
Habu, Masako
Okuno, Misako
Suzuki, Junichi
Takahashi, Shori
DIABETES, 2014, 63 : A323 - A323
[48] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
Dailey, G
Rosenstock, J
Moses, R
Ways, K
DIABETOLOGIA, 2004, 47 : A265 - A266
[49] Glycemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with type 2 diabetes
Dailey, G
Rosenstock, J
Moses, R
Ways, K
DIABETES, 2004, 53 : A121 - A121
[50] Effectiveness of one-year insulin glargine and insulin glulisine basal-bolus treatment in people with type 2 diabetes
Jermendy Gyorgy
Kovacs Gabor
ORVOSI HETILAP, 2018, 159 (50) : 2122 - 2128

← 1 2 3 4 5 →